Connect with us

Hi, what are you looking for?

Jewish Business News


Israeli Mediwound Begins Trading On Nasdaq

The burns and wounds treatment developer is issuing 5 million shares at $14 each.


Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at
Thank you.

Burns and wounds treatment developer Mediwound will begin trading on the US Nasdaq market today. Clal Biotechnology Industries Ltd. (TASE: CBI), which holds a controlling 63% stake in Mediwound today notified the Tel Aviv Stock Exchange about the pricing of the IPO.

Credit Suisse Securities LLC, Jefferies, BMO Capital Markets and Oppenheimer & Co. are the underwriters. They will be offered the option to purchase 750, 000 additional regular shares at $14, which can be realized no later than 30 days from the IPO.

MediWound’s shares will begin trading Thursday under the MDWD ticker with the IPO to be completed no later than Tuesday March 25.

Published by Globes [online], Israel business news – 



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.

Copyright © 2021 Jewish Business News